Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity
Alzheimer's & Dementia · 2025-10 · 21 (10)
DOI: 10.1002/alz.70805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.10.2025. Verfasst von Juliette H Lanskey und 17 weiteren Autor:innen. Beteiligte Einrichtung: MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Pyramidal Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIHR Cambridge Biomedical Research Centre, Alzheimer's Research Trust.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alzheimer's disease (AD) affects neurophysiology by loss of neurons, synapses, and neurotransmitters. A mechanistic understanding of the human disease will facilitate new treatments. METHODS Magnetoencephalography was recorded during an auditory mismatch negativity paradigm from healthy adults ( n = 14) and people with symptomatic AD ( n = 45, amyloid biomarker positive) at baseline and after 16 months. Fourteen people with AD had repeat magnetoencephalography at 2 weeks to assess test–retest reliability. Dynamic causal models were fitted to the evoked responses and analyzed using parametric empirical Bayes. RESULTS Sensor data confirmed that AD and its progression reduce the mismatch negativity amplitude, which had excellent test–retest reliability. Parametric empirical Bayes analyses confirmed that AD progressively reduces extrinsic connectivity between pyramidal cells and superficial pyramidal cell gain modulation. DISCUSSION Dynamic causal modeling revealed cellular‐level causes of the neurophysiological deficits observed in AD. This approach may help facilitate experimental medicine studies of candidate treatments. Highlights Magnetoencephalography scanning provides reliable biomarkers that are sensitive to Alzheimer's disease (AD) and its progression, and informative about disease mechanisms underlying cognitive decline. In vivo assays of pyramidal cell function during cognitive processes in humans improve our understanding of AD mechanisms. The amplitude of the mismatch negativity response is progressively reduced in AD. Reduced pyramidal cell gain and connectivity underlie this neurophysiological deficit. These measures are potential biomarkers for interventional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
- Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
- Centre for Human Brain Health, School of Psychology, University of Birmingham, Edgbaston, Birmingham, UK.
- Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, UK.
- Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, USA.
- Cambridge Biomedical Campus, Neuroscience, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
ORCID-Profile: James B Rowe
Förderung
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- Alzheimer's Research Trust
- Dementias Platform UK
- NIHR Oxford Health Biomedical Research Centre
- Wellcome Trust
Zitieren
APA
Lanskey, J. H., Jafarian, A., Karadag, M., Kocagoncu, E., Williams, R. S., Yadav, P., Quinn, A. J., Pitt, J., Thayanandan, T., Lowe, S., Perkinton, M., Timmers, M., Raymont, V., Singh, K. D., Woolrich, M., Nobre, A. C., Henson, R. N., & Rowe, J. B. (2025). Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity. Alzheimer's & Dementia, 21(10). https://doi.org/10.1002/alz.70805
Vancouver
Lanskey JH, Jafarian A, Karadag M, Kocagoncu E, Williams RS, Yadav P, et al. Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity. Alzheimer's & Dementia. 2025;21(10). doi:10.1002/alz.70805
BibTeX
@article{Lanskey2025,
author = {Lanskey, Juliette H and Jafarian, Amirhossein and Karadag, Melek and Kocagoncu, Ece and Williams, Rebecca S and Yadav, Pranay and Quinn, Andrew J and Pitt, Jemma and Thayanandan, Tony and Lowe, Stephen and Perkinton, Michael and Timmers, Maarten and Raymont, Vanessa and Singh, Krish D and Woolrich, Mark and Nobre, Anna C and Henson, Richard N and Rowe, James B},
title = {Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {10},
doi = {10.1002/alz.70805}
}
EUVIMED